Zobrazeno 1 - 10
of 415
pro vyhledávání: '"Yukio, Maruyama"'
Autor:
Munekazu Ryuzaki, Yasuhiko Ito, Hidetomo Nakamoto, Yuichi Ishikawa, Noritomo Itami, Minoru Ito, Atsushi Ueda, Yoshie Kanazawa, Hideki Kawanishi, Yoshihiko Kanno, Hitoshi Sugiyama, Kazuhiko Tsuruya, Hiroyuki Terawaki, Tadashi Tomo, Mizuya Fukasawa, Akihiro C. Yamashita, Hideki Yokoi, Masaaki Nakayama, Hidemichi Yuasa, Yasushi Tsujimoto, Hiraku Tsujimoto, Yosuke Saka, Yusuke Kuroki, Kaoru Yasuda, Takayuki Fujii, Atsuhiro Kanno, Emi Fujikura, Kimio Watanabe, Yoko Obata, Miho Murashima, Naohiro Toda, Shuto Yamamoto, Yoshihiro Tsujimoto, Tsutomu Sakurada, Daisuke Komukai, Kiyotaka Uchiyama, Naoki Washida, Kohkichi Morimoto, Takahiro Kasai, Yukio Maruyama, Chieko Higuchi, Hiroaki Io, Keiichi Wakabayashi, on behalf of the Working Group on Revision of Peritoneal Dialysis Guidelines of the Japanese Society for Dialysis Therapy
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-20 (2021)
Abstract Background This article is a duplicated publication from the Japanese version of “2019 JSDT Guidelines for Peritoneal Dialysis” with permission from the Japanese Society for Dialysis Therapy (JSDT). This clinical practice guideline (CPG)
Externí odkaz:
https://doaj.org/article/b2bc12191c924667b9fa46d1f0918730
Autor:
Yukio Maruyama, Takanori Kumagai, Naoki Sugano, Shigetaka Yoshida, Kimiyoshi Ichida, Shunya Uchida
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-11 (2021)
Abstract Background Whether uric acid (UA)-lowering therapy (ULT) is effective in reducing the progression of renal dysfunction in patients with chronic kidney disease (CKD) remains controversial. Since several advances have been made in therapies fo
Externí odkaz:
https://doaj.org/article/037e06d7105a4f6e8900c9d7ecd61caa
Autor:
Keita Morimoto, Go Kanzaki, Takahito Niikura, Kentaro Koike, Nanae Matsuo, Yukio Maruyama, Nobuo Tsuboi, Takashi Yokoo
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-6 (2021)
Abstract Background Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis usually induces rapidly progressive glomerulonephritis, including pauci-immune necrotizing crescentic glomerulonephritis. Acute tubulointerstitial nephritis (ATIN),
Externí odkaz:
https://doaj.org/article/edaf8d4484fa4d0c813e15aed244b64b
Autor:
You Komatsuzaki, Masato Ikeda, Akihiro Shimizu, Nanae Matsuo, Yukio Maruyama, Takashi Yokoo, Hiroyuki Yamamoto, Nobuhiko Joki, Ryoichi Ando, Daijo Inaguma, Toshihiko Yamaka, Masaaki Nakayama, Fumihiko Koiwa, Shinya Kawamoto, Shigeo Negi, Takashi Shigematsu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract The traditional anion gap (AG) equation is widely used, but its misdiagnosis in end-stage kidney disease (ESKD) patients has not been investigated fully. Diagnostic accuracy to detect high AG was cross-sectionally evaluated using 3 AG equati
Externí odkaz:
https://doaj.org/article/0fcf2bd3df1a45e48ba154fdb6a19daf
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-14 (2020)
Abstract The long-term clinical experiences with recombinant human erythropoietin (rHuEPO) and its analog derivatives have clearly proven that correction of anemia with erythropoiesis stimulating agent (ESA) not only reduces blood transfusion and imp
Externí odkaz:
https://doaj.org/article/fb280e5f15e3467a8689d3cbe8edbe2d
Autor:
Kyohei Ogawa, Yukio Maruyama, Nanae Matsuo, Yudo Tanno, Ichiro Ohkido, Keita Hirano, Masato Ikeda, Takashi Yokoo
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-6 (2020)
Abstract Background Catheter dysfunction, especially omental wrapping, is a serious complication of peritoneal dialysis (PD). Although catheter implantation at a lower site was reported to prevent omental wrapping, this method could induce insufficie
Externí odkaz:
https://doaj.org/article/10bc627b9d9e423a946bfa66bf77b6e0
Autor:
Masamitsu Morishita, Yukio Maruyama, Masatsugu Nakao, Nanae Matsuo, Yudo Tanno, Ichiro Ohkido, Masato Ikeda, Takashi Yokoo
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background Chronic kidney disease-mineral and bone disorder (CKD-MBD) management in patients with end-stage renal disease is important owing to the risk of cardiovascular diseases. In clinical practice, we manage patients not by monitoring t
Externí odkaz:
https://doaj.org/article/8bbd8da16247439886babf3c47247105
Publikováno v:
PLoS ONE, Vol 17, Iss 4 (2022)
Background Higher serum β2-microglobulin (B2M) concentrations are associated with higher mortality in the general population, non-dialyzed chronic kidney disease patients and patients receiving hemodialysis (HD). However, this relationship among pat
Externí odkaz:
https://doaj.org/article/d78c3b81704c4524aa70d56a2f11422d
Autor:
Yukio Maruyama, Chieko Higuchi, Hiroaki Io, Keiichi Wakabayashi, Hiraku Tsujimoto, Yasushi Tsujimoto, Hidemichi Yuasa, Munekazu Ryuzaki, Yasuhiko Ito, Hidetomo Nakamoto
Publikováno v:
Renal Replacement Therapy, Vol 5, Iss 1, Pp 1-12 (2019)
Abstract Background Diabetes has become the most common cause of end-stage renal disease (ESRD) requiring renal replacement therapy (RRT) in most countries around the world. Peritoneal dialysis (PD) is valuable for patients newly requiring RRT becaus
Externí odkaz:
https://doaj.org/article/1822b77f61f1487c854c07e4d0c553b8
Publikováno v:
Renal Replacement Therapy, Vol 5, Iss 1, Pp 1-8 (2019)
Abstract Background Schistocytosis, which is often observed in thrombotic thrombocytopenic purpura (TTP) patients, is a rare complication in myelodysplastic syndrome (MDS) patients. Case presentation We report on a 59-year-old man with progressive an
Externí odkaz:
https://doaj.org/article/ac57d5af85b64e84a4921d5a2f14708f